Ardelyx, Inc. is a biopharmaceutical company based in California. It lobbies Congress on Medicare and Medicaid issues, especially coverage and payment rules under Medicare Part D (the prescription drug benefit). Recent filings show it also engaged on reimbursement matters and a bill called the Kidney PATIENT Act. It hired Roberti Global for lobbying work.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
mr STEVEN E IRIZARRY
The latest disclosures for this client.
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Q3ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Q2The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
VINCENT A. ROBERTI, SR.
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Q1ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Q4ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Q3ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Q2ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Q1